the 2 biological drug treatments for AN are: SSRI (selective serotonin reuptake inhibitor) and antipsychotic
how do SSRIs work
SSRI is an antidepressant
functions by blocking serotonin reuptakes and preventing serotonin in the synapse from being reabsorbed into presynaptic neuron - increasing overall availability of serotonin in the synapse
serotonin binding is beneficial in maintenance of appetite which help individuals have a less restrictive diet
SSRI can alleviate symptoms of AN:
helps put on weight
less obsessive thoughts about food
reduces overall anxiety levels as SSRIs affect the entire brains serotonin which leads to overall increase of mood lessening anxiety
SSRI can reduce the likelihood of relapse
what is a common SSRI
a common SSRI is fluoxetine - used to treat anxiety and depressive comorbid symptoms of patients with AN
what are antipsychotics
antipsychotic drugs act as dopamine antagonists
occupy dopamine D2 receptors in neurons dendrites but don't activate them.
they can lessen the effects of dopamine leading to lower anxiety levels in food as they regulate overactive dopamine system in people with AN
what is olanzapine
a common atypical antipsychotic drug is olanzapine - targets both dopamine and serotonin receptors
blocks D2 receptors stopping the absorption of dopamine and blocking 5-HTA receptors for serotonin in neural pathways within the brain
helps to alter motivation and reward perception
drug can help reduce obsessive thoughts about food which decrease patients anxiety at meal times so encouraging regular eating and helping recovery
what is olanzapine linked to
increasing production of ghrelin (hunger hormone)
taking this drug will induce appetite resulting in weight gain as a side effect - useful as AN patients have significantly low body weight for age and sex
strength of biological treatment
research evidence of drugs improving AN symptoms
boachie (2003) used olanzapine to treat 4 children with AN -gained a kg of weight a week and experienced less anxiety at meal times
antipsychotics can treat AN symptoms of extremely low body weight
weakness (counter)
small sample size
research not applicable to people of older age
therefore, results not as reliable as we dont know the effects of olanzapine on adults
strength
drug improved AN symptoms
jensen and mejlhede (2000) - case studies of 3 patients who took olanzapine - patients showed an increase in positive body image more realistic of what they actually looked like
antipsychotic can treat AN symptom of a distorted perception of ones body shape or size
weakness
difficulties in convincing patients to take drug and continue within first 2 months
it takes a few weeks before a full antipsychotic effect is achieved
therefore, as these drugs take time to have effects and have side effects such as: dizziness and constipation, it may be challenging for patients to use olanzapine
weakness
effectiveness of drugs in treating AN is being challenged
lebrow (2013) found people with AN who take antipsychotics have increases in BMI and body satisfaction but were not significantly different than those in placebo groups - some instances were associated with higher anxiety levels
drug therapies might not be an effective treatment for AN
what are the NICE guidelines
NICE (national institute for health and care excellence) - do not recommend using drug therapy as a first choice for AN, as they affect weight gain and depression in patients
role is to improve outcomes for people using the NHS and other public healthcare services